CARDIAC ALLOGRAFT VASCULOPATHY
Clinical trials for CARDIAC ALLOGRAFT VASCULOPATHY explained in plain language.
Never miss a new study
Get alerted when new CARDIAC ALLOGRAFT VASCULOPATHY trials appear
Sign up with your email to follow new studies for CARDIAC ALLOGRAFT VASCULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could early blood thinners save heart transplants?
Disease control Recruiting nowThis study tests whether starting blood thinners (antiplatelet drugs) soon after a heart transplant can prevent a common complication called cardiac allograft vasculopathy, which narrows the heart's arteries. About 135 adult heart transplant recipients will be randomly assigned t…
Matched conditions: CARDIAC ALLOGRAFT VASCULOPATHY
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated May 26, 2026 10:16 UTC
-
Heart transplant patients may soon skip invasive scans thanks to new PET study
Knowledge-focused Recruiting nowThis study compares a noninvasive PET scan to the standard invasive coronary angiography for monitoring heart transplant patients for a condition called cardiac allograft vasculopathy (CAV), which narrows heart arteries. Researchers will enroll 576 adults who are 2-10 years post-…
Matched conditions: CARDIAC ALLOGRAFT VASCULOPATHY
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated May 26, 2026 10:08 UTC